Home »
PRESS RELEASE: Advancing Digital Health Technologies to Improve Medication Adherence Across Europe
After four years of working together, ENABLE COST Action, dedicated to enhancing medication adherence across Europe through the advancement of digital health technologies, successfully concluded its last Management Committee Meeting in Istanbul, Turkey.
Throughout the meeting held from April 5-6, 2024, esteemed representatives from leading academic institutions and healthcare organizations convened to chart the course for the Action’s future endeavours. The collaborative efforts aimed to address the critical issue of medication non-adherence through innovative technological solutions.
ENABLE COST Action is a groundbreaking initiative comprising a network of experts from across Europe, united in their commitment to harnessing digital innovations to improve patient outcomes. With representation from multiple countries, the Action is poised to make significant impacts in healthcare on a pan-European scale.
The meeting served as a platform for intensive discussions, knowledge exchange, and strategic planning to disseminate the Action’s objectives forward. Key highlights from the gathering include:
- Identification of Priorities:
- Participants engaged in a dialogue to identify key priorities and focus areas for the dissemination of the Action outcomes, ensuring alignment with the overarching goal of enhancing medication adherence.
- Collaborative Action Plans:
- The Management Committee developed collaborative action plans aimed at leveraging digital health technologies to address the multifaceted challenges associated with medication non-adherence, that have emerged in an open repository of MATech (medication adherence enhancing technologies). Barriers and unmet needs from the healthcare professional perspective have also been highlighted.
- Strategic Partnerships:
- Stakeholders explored opportunities for strategic partnerships and synergies with relevant stakeholders, including healthcare providers, technology developers, and policymakers, to maximize the impact of ENABLE COST Action. An international conference will be held in Brussels next summer to push forward these synergies.
- Commitment to Impact:
- Participants reaffirmed their commitment to driving Action outcomes and creating a lasting impact on medication adherence across Europe.
- As ENABLE COST Action moves forward, it remains dedicated to advancing the frontiers of digital health technologies, fostering collaboration, and driving positive change in healthcare systems across Europe. Through continued collaboration and collective efforts, the project aims to realize its vision of enhancing medication adherence and improving patient outcomes for all.
- For more information about ENABLE COST Action and its initiatives, please visit:
- www.enableadherence.eu
- Contact:
- Job van Boven, Action Chair, University Medical Center Groningen, Netherlands,
- j.f.m.van.boven@rug.nl
- Björn Wettermark, Science Communication Manager, Uppsala University, Sweden,
- bjorn.wettermark@farmaci.uu.se
- Stakeholders explored opportunities for strategic partnerships and synergies with relevant stakeholders, including healthcare providers, technology developers, and policymakers, to maximize the impact of ENABLE COST Action. An international conference will be held in Brussels next summer to push forward these synergies.
- About ENABLE COST Action: The COST Action “European Network to Advance Best practices & technoLogy on medication adherencE” (ENABLE) CA19132 aims to create a multidisciplinary network of relevant stakeholders that work collaboratively towards economically viable implementation of medication adherence enhancing technologies across different European healthcare systems.
- ENABLE COST Action Last Management Committee Meeting on April 5-6, 2024 in Kalamış, Istanbul, Turkey
- Local organiser: Gaye Hafez, Istanbul, Turkey
